Global Alcohol Use Disorder Treatment Market to Reach USD 1,300 million by 2033 at a 6.4% CAGR, Driven by Rising Incidence of Alcohol Abuse

Alcohol Use Disorder Treatment Market
Alcohol Use Disorder Treatment Market

The global Alcohol Use Disorder Treatment Market is projected to experience substantial growth over the coming decade, with market value expected to rise from USD 700 million in 2023 to USD 1.300 Million by 2033, at a robust compound annual growth rate (CAGR) of 6.4%.

This growth is primarily driven by the rising incidence of alcohol abuse and binge drinking across the globe, as these issues continue to impact individuals regardless of age or gender. The increasing awareness surrounding alcohol use disorder (AUD) and its far-reaching consequences has led to a greater demand for effective treatment options, further propelling market expansion.

Key Market Insights:

  • Market Value in 2023: US$ 700 million
  • Projected Market Value by 2033: US$ 1.3 billion
  • CAGR (2023-2033): 6.4%

Alcohol use disorder is a widespread and serious condition that affects millions of people worldwide. Its non-discriminatory nature creates a substantial and growing market for treatments, including therapies, medications, and counseling services. The rise in public health initiatives and government programs aimed at addressing alcohol addiction is expected to further support the industry’s growth in the coming years.

The global market is also seeing advancements in the development of new and more effective treatments, offering promising solutions for those seeking recovery from alcohol dependence. Innovations in medication-assisted treatment (MAT) and behavioral therapies are likely to improve the success rates of treatment programs, contributing to the long-term expansion of the alcohol use disorder treatment market.

Several countries have seen an increase in patient awareness, an increase in treatment-seeking frequency, increased government participation, and a greater emphasis on addiction prevention as a result of drug awareness campaigns and accompanying preventative programmes. To communicate knowledge, television advertising, newspapers, information pamphlets, and other forms of media are used, all of which aid in market expansion. As The number of people effectively treated for AUD is increasing as a result of new drugs that prevent deterioration while also managing alcohol urges.

Each year, over 30,000 people die in the United States as a result of liver cirrhosis, the vast majority of which are caused by alcohol consumption. North America dominates the market for AUD treatment due to the availability of treatment drugs and a well-developed health infrastructure. Since India and China are the world’s two most populous countries, Asia Pacific has the highest population density. The Asia-Pacific region is expected to grow at a high rate from 2023 to 2033, owing to an increase in vulnerable adult population and increased demand for AUD treatment.

Key Takeaways from the Market Study

  • According to FMI, the worldwide Alcohol Use Disorder Treatment market would grow at a 6.4% value CAGR by 2033.
  • The global Alcohol Use Disorder Treatment market is expected to be worth US$ 700 million.
  • The global Alcohol Use Disorder Treatment market is anticipated to be worth US$ 1,300 million.
  • Europe is expected to be the most profitable region for Alcohol Use Disorder Treatment market growth.
  • North America is predicted to increase at a CAGR of 6.2% between 2023 and 2033.
  • According to Future Market Insights, Asia Pacific is predicted to develop at a CAGR of 6% from 2023 to 2033.
  • The alcohol abuse segment is expected to hold the largest market share for Alcohol Use Disorder Treatment in the forecast period 2023 to 2033.

“Drug awareness programmes and addiction & recovery facilities among the people are considerably contributing to market growth. One of the most important aspects of the development of the Alcohol Use Disorder Treatment industry is the use of awareness campaigns and associated anticipatory programmes,” says an analyst at FMI.

Market Competition

Prominent players in the Alcohol Use Disorder Treatment market are Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX THERAPEUTICS, Kinnov Therapeutics, Opiant Pharmaceuticals, Omeros Corporation, GlaxoSmithKline plc and Merck & Co. Inc.

  • BioCorRx Inc., a developer and provider of innovative treatment programmes for substance abuse and related disorders, announced a partnership with Government Plus LLC, a leading provider of private sector healthcare to veterans, in December 2022, to expand its Beat Addiction Recovery Programme across the country.
  • Opiant Pharmaceuticals Inc. announced in November 2022 that it has agreed into a final merger agreement with Indivior Inc, a subsidiary of Indivior PLC, to be acquired. Indivior will buy all of Opiant’s existing shares for $20.00 per share in cash at closing, plus contingent value rights (CVRs) reflecting potential further payments of up to $8.00 per share over a seven-year period if the acquisition is completed.

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global Alcohol Use Disorder Treatment market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

A Full Report Overview

Key Segments:

By Disorder Type:

  • Alcohol Abuse
  • Alcohol Dependence
  • Alcohol Addiction
  • Alcoholism

By Treatment Type:

  • Medication
  • Therapy
  • Multidisciplinary Treatment

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Biosensors Market Poised for Significant Growth, Projected to Reach USD 65.2 Billion by 2033 at a 9.5% of CAGR

Global Biosensors Market
Global Biosensors Market

The Biosensors Market reached a global size of USD 24.5 billion in 2022. With a robust compound annual growth rate (CAGR) of 9.5% projected from 2023 to 2033, the market is expected to witness significant growth, surpassing historical trends.

Medical biosensors are anticipated to be the highest revenue-generating segment within the biosensors market, with projections indicating a CAGR of over 10.5% during the forecast period. This growth is driven by the increasing demand for innovative and accurate diagnostic tools in healthcare, which are critical for enhancing patient care and treatment outcomes.

Key Market Insights:

  • Global Market Size (2022): US$ 24.5 billion
  • Projected CAGR (2023-2033): 9.5%
  • Expected Growth of Medical Biosensors: Over 10.5% CAGR

The rising prevalence of chronic diseases, combined with an aging population, is fueling the demand for advanced biosensing technologies. As healthcare systems continue to focus on personalized medicine and early detection, the role of biosensors in monitoring health conditions and providing timely interventions becomes increasingly vital.

Furthermore, technological advancements in biosensor development—such as miniaturization, improved sensitivity, and integration with digital health platforms—are expected to enhance the efficacy and usability of these devices, thereby driving market expansion.

As the biosensors market evolves, stakeholders are encouraged to invest in research and development initiatives to create innovative biosensing solutions that address emerging healthcare challenges.

Competitive Analysis

With the increased demand for biosensors, global manufacturers are accelerating and improving their manufacturing processes with cost-effective solutions. A few of the key players in the biosensors market include Bio-Rad Laboratories Inc., Medtronic, Abbott Laboratories, Biosensors International Group, Ltd., Pinnacle Technologies Inc., Ercon, Inc., DuPont Biosensor Materials, Johnson & Johnson, Koninklijke Philips N.V., LifeScan, Inc., QTL Biodetection LLC, Molecular Devices Corp., Nova Biomedical, Molex LLC, TDK Corporation, Zimmer & Peacock AS, and Siemens Healthcare.

Some of the recent developments of key Biosensors providers are as follows:

  • In January 2022, Roche and Sysmex signed a Global Business Partnership Agreement (GBP) to supply hematological diagnostic services. Using IT technology, the new cooperation aims to enhance clinical decision-making and consumer experience. This long-standing, fruitful collaboration is still going strong, offering hematological diagnostic improvements to labs all over the world.
  • In December 2020, Abbott announced that Health Canada has authorized FreeStyle Libre 2, its next-generation sensor-based glucose monitoring gadget, for adults and children (4 years and older) with diabetes.
  • In December 2020, Bio-Rad Laboratories announced an expansion of its marketing agreement jointly with Siemens Healthineers. Under the agreement, Bio-Rad will offer quality control products and Unity Quality Control data management solutions for Atellica Solution platforms of Siemens Healthineers.
  • In November 2020, Medtronic announced the release of InPen with real-time CGM data from Guardian Connect. InPen is the first and only FDA-approved smart insulin pen for those who need large numbers of injections on a daily basis (MDI).
  • In October 2020, Bio-Rad Laboratories announced that they would launch their CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems, as well as BR.io, a cloud-based instrument connectivity and data management platform.

Similarly, recent developments related to the companies in the Biosensors market have been tracked by the team at Future Market Insights, which are available in the full report.

A Full Report Overview

Market Segments Covered in Biosensors Market Analysis

By Product Type:

  • Medical
    • Cholesterol
    • Blood Glucose
    • Blood Gas Analyzer
    • Pregnancy Testing
    • Drug Discovery
    • Infectious Disease
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others

By Technology:

  • Thermal
  • Electrochemical
  • Piezoelectric
  • Optical

By End-Use:

  • Home Healthcare Diagnostics
  • PoC Testing
  • Food Industry
  • Research Laboratories
  • Security & Biodefense

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Babesiosis Treatment Market Set to Reach USD 1.98 Billion by 2033 at a 5.0% of CAGR

Global Babesiosis Treatment Market
Global Babesiosis Treatment Market

The global Babesiosis Treatment Market is anticipated to be valued at USD 1.21 billion in 2023, with projections indicating robust growth at a compound annual growth rate (CAGR) of 5.0% between 2023 and 2033. By the end of this forecast period, the market is expected to reach approximately USD 1.98 billion.

The growth of the Babesiosis Treatment Market can be attributed to ongoing advancements in drug development and biotechnology aimed at effectively treating babesiosis, a tick-borne disease caused by the Babesia parasite. As research and innovation continue to evolve in this field, the market is poised for significant expansion.

Key Market Insights:

  • Projected Market Value for 2023: US$ 1.21 billion
  • Expected Valuation by 2033: US$ 1.98 billion
  • CAGR (2023-2033): 5.0%

The increasing prevalence of babesiosis, particularly in regions with high tick populations, is driving the demand for effective treatment options. Healthcare providers are increasingly recognizing the importance of timely diagnosis and intervention, which further fuels market growth.

Moreover, the rising awareness among healthcare professionals and patients regarding the symptoms and complications associated with babesiosis is expected to enhance early detection and treatment outcomes. This growing focus on preventative care and effective management strategies is critical in combating the disease and improving patient quality of life.

As the Babesiosis Treatment Market continues to develop, stakeholders are encouraged to invest in research and development initiatives that can lead to innovative treatment solutions, ultimately addressing the unmet needs of patients affected by this disease.

According to the analysis of Future Market Insights, major factors such as an increase in the number of cases of Lyme disease, and the extensive possibility for the growth of antibiotics for curing patients having babesiosis are anticipated to fuel the growth of the babesiosis treatment market during the analysis period. For instance, International Lyme and Associated Disease Society (ILADS) recommends customized antibiotic treatment for the patients depending on their response to treatment, as Lyme disease is hard to diagnose, which results in persistent infection. However, the treatment of antibiotics cannot reduce the infection of Lyme disease, which in turn gives a wider scope for the development of ideal antibiotic treatment of babesiosis.

Additionally, in March 2018, the USA Food and Drug Administration approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, as well as the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples. These tests were intended to be used as donor screening tests on samples from individual human donors, including volunteer donors of whole blood and blood components, as well as living organ and tissue donors.

Key Companies Profiled

  • GlaxoSmithKline LLC
  • Amneal Pharmaceuticals LLC
  • Apotex
  • Glenmark
  • Hetero
  • Lupin
  • Camber Pharmaceuticals, Inc.
  • Galderma
  • Fresenius Kabi
  • About
  • Pfizer, Inc.
  • Taro Pharmaceutical Industries
  • Otto Pharmaceutical
  • Medpharma
  • Endure Medical
  • Huajin Pharmaceutical
  • Mylan Pharmaceutical Inc.
  • Tabuk Pharmaceutical
  • Aurobindo Pharma Ltd
  • Epic Pharma LLC.

A Full Report Overview

Key Segments Covered in the Babesiosis Treatment Industry Analysis

Babesiosis Treatment Market by Drug Type:

  • Branded
  • Generic

Babesiosis Treatment Market by Route of Administration:

  • Oral
  • Injectable
  • Others

Babesiosis Treatment Market by End-Users:

  • Hospitals
  • Academic Research Institutes
  • Home Healthcare
  • Others

Babesiosis Treatment Market by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Babesiosis Treatment Market by Region:

  • North America
  • Europe
  • Europe
  • Latin America
  • Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Klinefelter Syndrome Therapeutics Market Expected to Reach USD 1.85 Billion by 2033 at a 5% of CAGR

Global Klinefelter Syndrome Therapeutics Industry
Global Klinefelter Syndrome Therapeutics Market

The global Klinefelter Syndrome Therapeutics Market is projected to surpass USD 1.14 billion in 2023, with an anticipated compound annual growth rate (CAGR) of 5% from 2023 to 2033. By the end of this forecast period, the market is expected to reach an impressive valuation of USD 1.85 billion.

Klinefelter syndrome, also known as 47, XXY, is a genetic condition characterized by the presence of an extra X chromosome. This common chromosomal disorder affects approximately one in every 500 individuals, yet many remain undiagnosed. Symptoms of Klinefelter syndrome can vary widely among patients, with some experiencing no observable indications of the condition.

Key Market Insights:

  • Projected Market Value for 2023: US$ 1.14 billion
  • Expected Valuation by 2033: US$ 1.85 billion
  • CAGR (2023-2033): 5%

The increasing awareness of Klinefelter syndrome and its symptoms is expected to drive demand for effective therapeutics and diagnostic solutions. As healthcare providers become more knowledgeable about this genetic condition, more individuals are likely to seek diagnosis and treatment, contributing to market growth.

In addition to greater awareness, ongoing research into Klinefelter syndrome’s implications and the development of targeted therapies are also expected to fuel the market. The emphasis on personalized medicine and innovative treatment strategies will play a crucial role in enhancing patient outcomes and quality of life for those affected by this condition.

The initiative is part of broader incentives for all types of health check-ups, anticipated to be a driving force behind the market’s growth in the years to come. The surge in men’s fertility disorders, coupled with an increase in clinical symptoms across all age groups, is expected to play a pivotal role in stimulating market expansion.

Europe is expected to be the second-fastest-growing region in the industry. The rising prevalence of the disease has enhanced research financing, and health organizations such as the National Institutes of Health (NIH) are focusing on raising awareness about the syndrome, which is cruising market growth. North America is expected to dominate the market due to the region’s large number of testosterone drugmakers, as well as increased awareness among the region’s population. In addition, a large number of treatment centers for this ailment will increase market share over the forecast period.

Market Competition

Key players in the Klinefelter syndrome therapeutics market are Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, Kyowa Kirin Co., Ltd, Pfizer Inc., AstraZeneca, AbbVie, Inc., Bausch Health Companies Inc., Bristol Myers Squibb Company, GSK Plc, Novartis AG, Viatris. Significant international pharma companies are researching the creation of numerous testosterone drugs, which will assist them to increase their market share. Some of the novel developments by key players are mentioned below:

  • Takeda Pharmaceutical Company Limited and Seagen Inc. declared that information from the Phase 3 ECHELON-1 clinical trial of an ADCETRIS® (brentuximab vedotin) plus chemotherapy combination would be introduced in a verbal meeting at the 59th American Society of Clinical Oncology (ASCO) Annual Meeting.
  • Pfizer Inc. introduced Testosterone Cypionate Injection in 2021 as a replacement therapy for males suffering from illnesses of endogenous testosterone deficiency or absence.

Key Companies Profiled

  • Hoffmann-La Roche Ltd.
  • Takeda Pharmaceutical Company Limited
  • Kyowa Kirin Co., Ltd
  • Pfizer Inc.
  • AstraZeneca
  • AbbVie, Inc.
  • Bausch Health Companies Inc.
  • Bristol Myers Squibb Company
  • GSK Plc
  • Novartis AG
  • Viatris

A Full Report Overview

Key Segments Profiled in the Klinefelter Syndrome Therapeutics Industry Report

By Therapeutics:

  • Testosterone Replacement Therapy
  • Fertility Treatment
  • Surgeries
  • Hormone Treatment
  • Others

By Application:

  • Hospitals
  • Specialty Clinics
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Marburg Virus Disease Therapeutics Market Projected to Reach USD 155 Million by 2033 at a 5.5% CAGR

Global Marburg Virus Disease Therapeutics Market
Global Marburg Virus Disease Therapeutics Market

The global Marburg Virus Disease Therapeutics Market is anticipated to achieve a market value of USD 90.74 million in 2023, with projections indicating growth to USD 155 million by 2033. This represents a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2023 to 2033.

The growth of the Marburg virus disease therapeutics market is primarily driven by the increasing prevalence of the Marburg virus across various geographical regions. As healthcare systems recognize the critical need for effective treatments and therapeutics, demand for Marburg virus disease therapeutics has demonstrated a CAGR of 4.1% during the historical period from 2018 to 2022.

Key Market Insights:

  • Projected Market Value for 2023: US$ 90.74 million
  • Anticipated Market Value by 2033: US$ 155 million
  • CAGR (2023-2033): 5.5%
  • Historical CAGR (2018-2022): 4.1%

The rising incidence of Marburg virus disease, particularly in endemic regions, underscores the urgent need for effective therapeutic interventions. This growing demand is prompting pharmaceutical companies and research institutions to invest in the development of innovative therapies to combat this severe viral infection.

As the global healthcare community mobilizes to address the challenges posed by emerging viral threats, the Marburg virus disease therapeutics market is expected to expand significantly. Continued research and development efforts, coupled with increasing awareness of the disease, will further enhance the market’s growth potential over the coming decade.

iddle East and Africa along with North America are the two major reasons contributing to the growth of the Marburg virus diseases therapeutics market. This is owing to the increasing cases of Marburg virus in Middle East and Africa whereas on the other hand, the strong presence of key players in North America is investing in research and development for Marburg virus diseases therapeutics.

Key Takeaways from the Market Study

  • The hospitals segment is expected to hold 45% of the market share in 2023 for Marburg virus disease therapeutics market.
  • The Marburg virus disease therapeutics market is expected to grow at a value of 5.5% CAGR for forecast period 2023-2033.
  • North America is expected to possess 43% market share for Marburg virus disease therapeutics market in 2023.
  • Asia Pacific Marburg virus disease therapeutics market size is expected to possess 39% market share in 2023.

“The increasing prevalence of Marburg virus disease along with investment in efforts for research and development for innovating therapeutics is creating lucrative opportunities for the market,”states an FMI analyst.

Market Competition

Key players in the Marburg virus disease therapeutics market are Amicus Therapeutics, Inc, Alexion Pharmaceuticals, Inc, BioCryst Pharmaceuticals, Bavarian Nordic, Bio-Rad Laboratories, Inc, AlphaVax, GW Pharmaceuticals plc, Takeda Pharmaceutical Company Limited, Alexion Pharmaceuticals, Inc, Mapp Biopharmaceutical, Collaborations Pharmaceuticals, Inc, Emergent BioSolutions Inc, BioMarin and Sarepta Therapeutics, Alkido Pharma, Biofactura

  • BioCryst Pharmaceuticals, a key player in the Marburg virus disease therapeutics market is focusing on undertaking research and development for understanding the nature of the virus and innovating therapeutic treatments for the same.
  • Bio-Rad Laboratories, Inc, another key player in the Marburg virus disease therapeutics market is integrating technology to understand the ailment and offering medication for treating the virus.

Key Companies Profiled

  • Amicus Therapeutics Inc.
  • Alexion Pharmaceuticals Inc.
  • BioCryst Pharmaceuticals
  • Bavarian Nordic
  • Bio-Rad Laboratories, Inc.
  • AlphaVax
  • GW Pharmaceuticals Plc
  • Takeda Pharmaceutical Company Limited
  • Mapp Biopharmaceutical
  • Collaborations Pharmaceuticals Inc.
  • Emergent BioSolutions Inc.
  • BioMarin and Sarepta Therapeutics
  • Alkido Pharma
  • Biofactura

A Full Report Overview

Key Segments Profiled in the Marburg Virus Disease Therapeutics Industry Survey

By Drug Classification:

  • Antiemetic
  • Nitro-glycerine
  • Loperamide
  • Antibiotics
  • Others

By Route of Administration:

  • Injectable
  • Oral
  • Parenteral

By End Users:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Durable Medical Equipment Rental Market Projected to Reach USD 47 Billion by 2033 at a 5.7% of CAGR

Global Durable Medical Equipment Rental Industry
Global Durable Medical Equipment Rental Industry

A newly released analysis report by Future Market Insights reveals that the Durable Medical Equipment (DME) Rental Market generated a revenue of USD 25.7 billion in 2022. With a compound annual growth rate (CAGR) of 5.7% expected from 2023 to 2033, the market is projected to reach a valuation of USD 47 billion by the end of the forecast period.

Hospitals are anticipated to be the largest revenue-generating segment within the DME rental market, with a projected growth rate of over 5.7% from 2023 to 2033. The increasing demand for medical equipment rentals in hospital settings is driven by several factors, including the need for cost-effective healthcare solutions and the rising prevalence of chronic diseases that require long-term management.

Key Market Insights:

  • Market Revenue in 2022: US$ 25.7 billion
  • Projected Market Value by 2033: US$ 47 billion
  • CAGR (2023-2033): 5.7%
  • Key Growth Segment: Hospitals, projected to grow at over 5.7% CAGR

The growth of the Durable Medical Equipment Rental Market is attributed to the increasing acceptance of rental services over purchasing equipment, especially in the context of budget constraints faced by healthcare facilities. Additionally, advancements in technology and product offerings are enhancing the efficiency and effectiveness of medical equipment rentals, further driving market expansion.

As the healthcare landscape continues to evolve, the DME rental market is expected to play a critical role in facilitating patient care while optimizing operational costs for healthcare providers. The rising trend of home healthcare services and outpatient care is also contributing to the growing demand for durable medical equipment rentals.

Despite predicted and exponential growth, healthcare operators continue to struggle to find a sustainable financing alternative to invest in cutting-edge technology and equipment in order to meet the demands of an increasingly demanding customer base. Renting medical equipment could be the next big thing in the global healthcare business, providing cost-effective and economical options during challenging economic times.

The absence of uniform regulatory criteria for medical equipment rental services, as well as high costs, are expected to limit the industry’s expansion. Furthermore, it has been discovered that few medical gadgets come with insurance, which will stymie the growth of the worldwide rental market for medical equipment.

In 2022, North America led the market. This is because of the country’s strong healthcare system and government support for privately operated hospitals, clinics, and diagnostic services.

As per the Durable Medical Equipment Rental Market research by Future Market Insights – a market research and competitive intelligence provider, historically, from 2018 to 2022, the value of the Durable Medical Equipment Rental Market increased at around 5.1% CAGR.

Despite projected and exponential expansion, operators in the healthcare industry continue to struggle to find a sustainable financing alternative to invest in cutting-edge technology and equipment to keep up with an increasingly demanding client base. Rental medical equipment might be the next big thing in the global healthcare market, giving economical and cost-effective choices during difficult economic times.

As technology improves and the need for capital advances, providers struggle with finances. It becomes difficult to handle the equipment and finance them. Hospitals use rental equipment to deal with the capital crunch. Equipment integration, recalls, and reductions in reimbursement, are other factors that shift the focus from acquiring medical devices to renting them for use.

Competitive Analysis

Some of the key players operating in the medical equipment rental market include Hill-Rom Holdings Inc., Stryker Corporation, Getinge AB, Siemens Financial Services Inc, Nunn’s Home Medical Equipment, Westside Medical Supply, Universal Hospital Services, Inc., Woodley Equipment Company Ltd., GE Healthcare, C.N.Y. Medical Products Inc., All American Medical Supply Corp., and Homepro Medical Supplies, LLC.

Some of the recent developments of key Durable Medical Equipment Rental providers are as follows:

  • In June 2020, MedOne Company announced the launch of a new facility in North Carolina. The USA, for the rental and service of medical equipment.
  • In March 2020, Med-Equip announced the acquisition of Martab’s equipment management services. The acquisition is being carried out to provide rentals of custom-made gadgets such as home testing kits.

Similarly, recent developments related to companies in the Durable Medical Equipment Rental Market have been tracked by the team at Future Market Insights, which are available in the full report.

A Full Report Overview

Market Segments Covered in Durable Medical Equipment Rental Market Analysis

By Application:

  • Personal Mobility Devices
  • Bathroom Safety and Medical Furniture
  • Monitoring and Therapeutic Devices

By End Use:

  • Personal/Homecare
  • Institutes and laboratories
  • Hospitals

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Thrombocytopenia Treatment Market Expected to Reach USD 10 Billion by 2033, Growing at a CAGR of 5.2%

Global Thrombocytopenia Treatment Industry
Global Thrombocytopenia Treatment Industry

The global Thrombocytopenia Treatment Market is projected to experience significant growth, with an anticipated compound annual growth rate (CAGR) of 5.2% from 2023 to 2033. The market is expected to reach a valuation of USD 10 billion by 2033, rising from USD 6 billion in 2023.

This growth is primarily driven by increasing morbidity and mortality rates associated with thrombocytopenia, affordable treatment options, and a growing awareness of the condition and its management. Thrombocytopenia, characterized by a low platelet count, can lead to serious health complications, necessitating effective treatment strategies.

Key Market Insights:

  • Projected Market Value for 2023: US$ 6 billion
  • Anticipated Market Value by 2033: US$ 10 billion
  • CAGR (2023-2033): 5.2%

Several factors are contributing to the expansion of the thrombocytopenia treatment market, including enhanced diagnostic capabilities, the development of novel therapies, and an increase in healthcare access. As awareness of thrombocytopenia grows, patients and healthcare providers are better equipped to manage the condition, leading to improved outcomes.

The rising demand for cost-effective treatment options is also playing a significant role in market growth. As pharmaceutical companies innovate and develop affordable therapies, they are meeting the needs of a broader patient population, which is crucial for addressing the challenges posed by thrombocytopenia.

Blood clots are due to platelets in the blood. Thrombocytopenia is defined as an abnormally low platelet count in the blood due to the presence of any illness or ailment. Individuals with thrombocytopenia have delayed or no blood clotting. Because of the high prevalence of thrombocytopenia and growing knowledge of treatment alternatives, the worldwide thrombocytopenia treatment market is likely to grow considerably in the near future.

Thrombocytopenia symptoms include nosebleeds, bruises, redness, and bleeding in the gums and mouth. Thrombocytopenia is discovered using tests such as a complete blood count (CBC) and a blood clotting study. Furthermore, biopsy and bone marrow aspiration are used to diagnose thrombocytopenia. According to a study published in Professional Med J in 2014 titled Incidence of Thrombocytopenia, the prevalence of thrombocytopenia is greater in persons aged 60 years and older who had non-cirrhotic liver disease. However, rapid discovery, along with the capacity to clone thrombopoietin, has resulted in novel therapeutic worldwide treatment options.

Market Competition

The thrombocytopenia treatment industry has experienced potential clinical breakthroughs as a result of ongoing guidelines changes. The 2018 American Society of Hematology (ASH) Guideline recommended a variety of alternative anticoagulant alternatives for doctors to consider.

Current practice recommendations in industrialized countries have prompted the development of novel thrombin inhibitors and immunoassays. This has increased therapy possibilities for acute thrombocytopenia treatment. Top players intend to introduce new anticoagulants to improve healthcare team outcomes. Manufacturers of assays and pharmaceuticals are focusing on lowering the probability of thromboembolic consequences.

Key players in the thrombocytopenia treatment market are 3SBio Inc., Amgen Inc., Takeda Pharmaceutical Company, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eisai Co., Ltd., Hansa Medical AB, Intas Pharmaceuticals Ltd. and Merck & Co., Inc.

Recent Developments:

  • In December 2021, Horizon Therapeutics Plc’s board of directors and Amgen Inc.’s board of directors announced that they have agreed on the terms of a cash offer for the Company by Pillartree Limited (Acquirer Sub), a newly formed private limited company wholly owned by Amgen, which is unanimously recommended by the Company Board and pursuant to which Acquirer Sub will acquire the entire issued and to be issued
  • In December 2020, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd., a subsidiary of 3SBio Inc., and Verseau Therapeutics, Inc. announced the selection of a monoclonal antibody targeting VSIG4 as a license program under their partnership arrangement aimed at the creation and commercialization of novel monoclonal antibodies in the field of immuno-oncology for a variety of cancers.

Key Companies Profiled:

  • 3SBio Inc.
  • Amgen Inc.
  • Takeda Pharmaceutical Company
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Hansa Medical AB
  • Intas Pharmaceuticals Ltd.
  • Merck & Co. Inc.

A Full Report Overview

Key Segments Profiled in the Thrombocytopenia Treatment Industry Survey

By Drug Class:

  • Glucocorticoids
  • Lysosomal Enzyme
  • Platelet Stimulating Agent

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Terrain Awareness and Warning System Market Anticipated to Cross USD 415 Million by 2033, Growing Steadily at 4.7% CAGR

The global terrain awareness and warning system market is estimated to be USD 245 million in 2023. The demand for terrain awareness and warning systems is projected to expand at a CAGR of 4.7%, with its market valuation reaching USD 415 million by 2033.

The global Terrain Awareness and Warning System (TAWS) market is on the brink of transformative growth, fueled by technological advancements, heightened safety concerns, and evolving regulatory landscapes. As we traverse the dynamic skies of innovation, several key factors are propelling the market forward, while a few challenges act as constraints. Here’s a closer look at the driving forces, restraints, and regional insights shaping the future of the TAWS market.

Key Drivers:

  1. Safety Imperative: The paramount concern for aviation safety is steering the TAWS market towards unprecedented growth. The increasing emphasis on avoiding Controlled Flight Into Terrain (CFIT) incidents has compelled airlines and aviation authorities to adopt advanced TAWS solutions.
  2. Technological Advancements: Continuous innovations in sensor technologies, data analytics, and machine learning are enhancing the capabilities of TAWS, providing pilots with real-time, actionable insights to navigate challenging terrains more effectively.
  3. Regulatory Mandates: Stringent regulations imposed by aviation authorities globally, including the Federal Aviation Administration (FAA) and the European Union Aviation Safety Agency (EASA), are compelling the widespread adoption of TAWS to enhance aviation safety standards.

Key Restraints:

  1. Cost Constraints: The initial investment required for implementing advanced TAWS solutions remains a challenge, particularly for smaller operators and airlines. Striking a balance between safety measures and budgetary constraints poses a considerable hurdle.
  2. Integration Challenges: Integrating TAWS into existing avionics systems can be complex and time-consuming. Compatibility issues with legacy systems may hinder the seamless adoption of TAWS across the aviation industry.

Key Factors and Regional Insights:

  1. Radar-Based TAWS: The market is witnessing a shift towards radar-based TAWS, offering enhanced accuracy and reliability in challenging weather conditions. This trend is particularly prominent in regions with diverse and unpredictable terrains.
  2. North America Dominance: North America is set to lead the TAWS market, driven by robust technological infrastructure, stringent safety regulations, and a high concentration of aviation activities. The United States is expected to be a major contributor to the regional growth.
  3. Asia-Pacific Emerging Markets: The Asia-Pacific region is experiencing significant growth, fueled by rising air travel demands, government initiatives promoting aviation safety, and increasing investments in modernizing aviation fleets.

As we navigate the skies of progress, the Terrain Awareness and Warning System market is poised for exponential growth. While addressing cost constraints and integration challenges, industry players are gearing up to redefine aviation safety standards globally.

Key Players:

  • Universal Avionics Systems Corporation
  • Honeywell International Inc.
  • L3 Technologies Inc.
  • Avidyne Corporation
  • Garmin
  • Collins Aerospace
  • Sandel Avionics
  • Aspen Avionics
  • Genesys Aerosystems
  • Mid-Continent Instruments and Avionics

Terrain Awareness and Warning System Market Segmentation:

By System Type:

  • Class A
  • Class B
  • Class C

By Engine Type:

  • Turbine Powered Systems
  • Piston Powered Systems

By Application:

  • Commercial Aircrafts
  • Civil Airlines
  • Chartered Planes
  • Civilian/Private Rotorcraft
  • Military & Defense Aircraft
  • Fighter Planes
  • Carrier Planes
  • Rotorcraft
  • Other Aircraft

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Access Report Details for More In-Depth Information!

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

FMI States Global General Purpose Electronic Test and Measurement Instruments Market to Reach USD 20.8 Billion by 2033, Growing at 9.7% CAGR

The global general purpose electronic test and measurement instruments market is poised for transformative growth, with projections indicating a significant valuation exceeding USD 20.8 billion by 2033, driven by a robust Compound Annual Growth Rate (CAGR) of 9.7% forecasted between 2023 and 2033. This substantial growth underscores the persistent demand for innovative solutions within the industry.

At the heart of this expansion is the increasing adoption of modular Test and Measurement (T&M) equipment, a trend gaining momentum across diverse sectors worldwide. The multifaceted benefits provided by modular systems are proving transformative, enabling enhanced flexibility, scalability, and cost-effectiveness. These advanced solutions are reshaping the landscape of testing, offering unmatched adaptability tailored to meet the unique requirements of various industries.

Stakeholders can anticipate a paradigm shift in precision testing, driven by the continual evolution of electronic test and measurement instruments.

Unlocking Growth: General Purpose Electronic Test and Measurement Instruments Market Insights

In today’s dynamic business landscape, it is crucial for organizations to stay ahead of the curve in terms of technology and innovation. The General Purpose Electronic Test and Measurement Instruments Market plays a pivotal role in ensuring the quality and efficiency of various industries. In this report, we delve into country-wise insights to understand how this market is expanding and contributing to business development.

Expanding Horizons: The United States Market

The United States stands at the forefront of technological advancements, and its General Purpose Electronic Test and Measurement Instruments Market is no exception. This market segment is set to experience substantial growth, primarily driven by increased demand from key sectors such as medical and IT & telecom.

Driving Factors in the United States:

The rapid evolution of technology, particularly in self-driving vehicles and the Internet of Things (IoT), has created a pressing need to enhance bandwidth and reduce latency—both of which are vital for unleashing the full potential of 5G technology. The United States is actively engaged in the national 5G business development league, positioning itself as a global leader in this domain.

Projections for the United States Market:

By 2033, the United States general purpose electronic test and measurement instruments market is expected to witness an impressive year-on-year growth rate of 9.6%. This signifies a substantial opportunity for businesses looking to invest in this sector. Moreover, the United States is poised to generate an incremental dollar opportunity of USD 3.8 million from 2023 to 2033, underlining its significance in the global market.

China’s Role in Market Expansion:

China has long been recognized as a manufacturing powerhouse, serving a diverse range of industries, including automotive, electrical, and electronics. As a leading producer of consumer electronics like mobile phones, tablets, laptops, and gaming consoles, China plays a pivotal role in shaping the global market for General Purpose Electronic Test and Measurement Instruments.

Key Drivers in China:

The growth of China’s automobile and electrical and electronics sectors has a profound impact on the demand for general purpose electronic test and measurement instruments. The transition to connected vehicles and intelligent transportation systems is a significant driving force behind this market’s expansion in China.

Bright Prospects for China’s Market:

Looking ahead, the Chinese market is projected to exhibit an impressive year-on-year growth rate of 9.6% by 2033. This growth trajectory is expected to translate into a substantial incremental dollar opportunity of USD 4.5 billion from 2023 to 2033, solidifying China’s position as a major player in the global market landscape.

Key Companies Profiled:

  • AstroNova, Inc
  • B&K Precision Corporation
  • Boonton Electronics
  • Fluke Corporation
  • Fortive Corporation
  • GaGe Applied Technologies, Inc.
  • Good Will Instrument Co., Ltd.
  • Hioki E. E. Corporation
  • Ideal Industries, Inc.

Market Segments by Category:

By Product:

  • Digital Oscilloscopes
  • Extension-Based T&M Instruments
  • Network Analyzers
  • Multimeters
  • Spectrum Analyzers
  • Radio Frequency Signal Generators
  • Microwave Signal Generators
  • Others

By End Use:

  • Communications
  • Aerospace & Defense
  • Electronics Manufacturing
  • Industrial Electronics & Automotive
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Access Report Details for More In-Depth Information!

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

FMI Study Affirms Global Copper Pipes and Tubes Market Revenue Share to Surpass USD 48.8 Billion by 2033, Driven by 3.2% CAGR Growth

The copper pipes and tubes market is poised for significant growth, projecting a Compound Annual Growth Rate (CAGR) of 3.2% over the forecasted period. This trajectory is expected to culminate in a substantial market value surpassing USD 48.8 billion by 2033.

This anticipated growth exceeds traditional statistical predictions, highlighting the enduring versatility and significance of copper across diverse applications. A pivotal catalyst driving this expansion is the increasing demand for HVAC (Heating, Ventilation, and Air Conditioning) units. With global construction activities gaining momentum, the installation of HVAC systems is on the rise, with copper pipes and tubes assuming a pivotal role. Renowned for their exceptional thermal conductivity, durability, and resistance to corrosion, these components emerge as the preferred choice, ensuring the efficient operation of heating and cooling systems.

Key Takeaways:

  • The United States copper pipes and tubes industry is estimated to attain USD 8.2 billion by 2033. Over the forecast period, the market is expected to expand at a CAGR of 3.1%. From 2018 to 2022, the market registered a CAGR of 4.4%.
  • The United Kingdom copper pipes and tubes industry is projected to be worth USD 1.8 billion by 2033. Over the estimated time, the market is projected to record a CAGR of 2.9%. Before this, the market registered a CAGR of 4.2%.
  • The China market stands prominently among the top-tier copper pipes and tubes economies. The market is expected to reach a valuation of USD 10.4 billion by 2033 end. From 2023 to 2033, the market is projected to expand at a CAGR of 3.1%.
  • The Japan market is projected to be valued at USD 9.4 billion by 2033. In the next ten years, the market is presumed to pace at a CAGR of 3.1%.
  • The South Korean copper pipes and tubes industry is projected to be valued at USD 2.5 billion by the end of 2033. Over the assessment period, the market is expected to expand at a CAGR of 2.8%.
  • Based on end use, the HVAC segment is expected to be at the top. The segment is expected to register a CAGR of 3%, as compared to the 4.1% CAGR recorded in the historical period.
  • The seamless copper pipes and tubes are expected to record a CAGR of 3.1% in the forecast period. The segment had grown at a CAGR of 4.2% in the historical period.

Competitive Landscape:

  • In February 2023, Mettube Copper India Private Limited, which is an Indian arm of the Malaysian firm, entered an arrangement with the Gujarat Government to establish its copper tube production factory in Sanand. The MNC has decided to invest around INR 1,000 crore in the first phase to set up the facility. The company’s copper tubes are used in the air conditioning and refrigeration industries. Since the plant is expected to produce 5th Gen copper tubes, the plant can be instrumental in reducing the carbon footprint in the future.
  • In January 2023, Lawton Tubes, a leading manufacturer of medical-grade copper tubes in the United Kingdom, announced that it may exhibit its expertise at Arab Health this year. The company has been a critical distributor of copper pipelines in and out of the United Kingdom, covering 35+ countries. At the event, the company is going to celebrate its assistance during the fight against COVID and discuss the feasibility of copper tubes in carrying medical gases.

Key Players:

Furukawa Electric Co., Ltd., Global Brass and Copper Holdings, Inc., ElvalHalcor, Mueller Industries, Aurubis AG, Cerro Flow Products LLC, Fabrika bakarnih cevi A.D. Majdanpek, Foshan Huahong Copper Tube Co., Ltd, Cambridge-Lee Industries LLC, H & H Tube, Zhejiang Hailiang Co., Ltd., Kobelco & Materials Copper Tube Co., Ltd., MM Kembla, Mehta Tubes Ltd., Qingdao Hongtai Copper Co., Ltd.

Key Segments Profiled:

By Product Type:

  • Seamless
  • Welded

By End Use:

  • HVAC
  • Industrial Heat Exchange
  • Plumbing
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

Access Report Details for More In-Depth Information!

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube